Ethical Compliance
CIPLA
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Market Cap Class:
large
Revenue
0.8%
Debt
0.8%
Liquidity
2.7%
Revenue
Debt
Liquidity
0.8%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other non-operating income | ₹526.98 |
| Revenue from sale of products | ₹25,446.63 |
| Technical know-how and licensing fees | ₹9.03 |
| Other operating revenue | ₹308.43 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹219.59 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹219.59 |
| Total: | ₹219.59 |
| Total Revenue: | ₹26,520.66 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹219.59
₹26,520.66
= 0.8%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
